Clinical benefit of second-generation long-acting injectable antipsychotics in preventing re-hospitalization in patients with schizophrenia: A real-world study in Japan-Reference-Cited by-同舟云学术

Clinical benefit of second-generation long-acting injectable antipsychotics in preventing re-hospitalization in patients with schizophrenia: A real-world study in Japan

Published:2023-08 Issue: Volume:86 Page:103671
ISSN:1876-2018
Container-title:Asian Journal of Psychiatry
language:en
Short-container-title:Asian Journal of Psychiatry

Author:

Kasahara-Kiritani Mami^ORCID,Saga Yosuke,Wakamatsu Akihide,Wu David Bin-Chia,Tsai I-Ching

Funder

Janssen Japan

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,General Psychology,General Medicine

Reference11 articles.

1. Drug utilization of japanese patients diagnosed with Schizophrenia: an administrative database analysis;Cheung;Clin. Drug Investig.,2017

2. Employment among people with Schizophrenia or bipolar disorder: a population-based study using nationwide registers;Holm;Acta Psychiatr. Scand.,2021

3. Optimizing treatment choices to improve adherence and outcomes in Schizophrenia;Kane;J. Clin. Psychiatry,2019

4. Direct healthcare cost of schizophrenia - European overview;Kovács;Eur. Psychiatry,2018

5. Antipsychotic adherence and rehospitalization in Schizophrenia patients receiving oral versus long-acting injectable antipsychotics following hospital discharge;Marcus;J. Manag Care Spec. Pharm.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder;Asian Journal of Psychiatry;2024-04

2. Gepirone-the latest antidepressant on market state-of-the-art or run-of-the-mill?;Asian Journal of Psychiatry;2024-04

3. Involuntary administration of long-acting injectable antipsychotics in hospitalized patients with schizophrenia who are incapable of providing informed consent;Asian Journal of Psychiatry;2024-02

4. Comparison of health resource usage and costs associated with first-generation and second-generation long-acting injectable antipsychotics for patients with schizophrenia: A nationwide population-based cohort study;Asian Journal of Psychiatry;2023-11